ArticleJournal of cancer research and clinical oncology2012

Enhanced ABL-inhibitor-induced MAPK-activation in T315I-BCR-ABL-expressing cells: a potential mechanism of altered leukemogenicity.

Nicolai Härtel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.